Tapewire

Nasdaq · USD

CRSP

CRISPR Therapeutics AG

Export transactions ↓
Tapewire entity
3852
SEC CIK
0001674416
Parsed reports
491

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202607
Feb 202602
Mar 2026010
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 03, 2025 Filed Oct 3, 2025 21:37 UTC
Patel NaimishChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 16,500 $0.00 Strike: $67.74 $0.00
Disclosure

SEC source: 0001193125-25-230508 · ownership.xml · derivative · entry 1

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Shares · 16,500 shares

Expires 2035-10-03

F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.

Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 49,500 $0.00 Strike: $67.74 $0.00
Disclosure

SEC source: 0001193125-25-230511 · ownership.xml · derivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,500

Underlying: Common Shares · 49,500 shares

Expires 2035-10-03

F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 49,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.

Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:36 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 16,500 $0.00 Strike: $67.74 $0.00
Disclosure

SEC source: 0001193125-25-230506 · ownership.xml · derivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Shares · 16,500 shares

Expires 2035-10-03

F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.

Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:36 UTC
Prasad RajuChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 16,500 $0.00 Strike: $67.74 $0.00
Disclosure

SEC source: 0001193125-25-230505 · ownership.xml · derivative · entry 1

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Shares · 16,500 shares

Expires 2035-10-03

F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 21:42 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GiftCommon Shares 6,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-209353 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,004

F1 · shares: The reporting person made a charitable contribution of common shares to a donor advised fund.

Read SEC document
August 18, 2025 Filed Aug 19, 2025 20:30 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 13,081 $58.15 $760,660.15
Disclosure

SEC source: 0001682019-25-000003 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,004

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2025 Filed Aug 19, 2025 20:30 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 25,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001682019-25-000003 · ownership.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025.

F3 · derivative.expiration_date: This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025.

Read SEC document
August 16, 2025 Filed Aug 19, 2025 20:30 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001682019-25-000003 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
August 06, 2025 Filed Sep 21, 2026 22:30 UTC OtherCommon Shares 15 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-396935 · ownership.xml · nonDerivative · entry 2

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 3

Disclosed balance after: 29

F2 · kind: The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.

F3 · ownership.nature: The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest.

Read SEC document
August 06, 2025 Filed Sep 21, 2026 22:30 UTC OtherCommon Shares 60 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-396935 · ownership.xml · nonDerivative · entry 1

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316

F1 · kind: NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.

Read SEC document
August 06, 2025 Filed Aug 8, 2025 20:06 UTC PurchaseCommon Shares 20,000 $57.03 $1,140,600.00
Disclosure

SEC source: 0001688192-25-000004 · ownership.xml · nonDerivative · entry 1

Treco Douglas A · CIK 0001688192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

F1 · kind: Open market purchase of shares in accordance with Issuer's trading policies.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.92 to $57.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 21:19 UTC PurchaseCommon Shares 960,983 $52.03 $49,999,945.49
Disclosure

SEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 3

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 3

Disclosed balance after: 1,730,179

F3 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 21:19 UTC PurchaseCommon Shares 22,319 $52.03 $1,161,257.57
Disclosure

SEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 2

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 2

Disclosed balance after: 238,897

F2 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 21:19 UTC PurchaseCommon Shares 6,510 $52.03 $338,715.30
Disclosure

SEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 1

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Note 1

Disclosed balance after: 69,687

F1 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners II, LP ("SR One Partners II"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083272 · ownership.xml · derivative · entry 1

Rommel Christian · CIK 0002022449 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083273 · ownership.xml · derivative · entry 1

Treco Douglas A · CIK 0001688192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:47 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083298 · ownership.xml · derivative · entry 1

George Simeon · CIK 0001595117 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:38 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083289 · ownership.xml · derivative · entry 1

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083274 · ownership.xml · derivative · entry 1

Morrison Briggs · CIK 0001654430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083271 · ownership.xml · derivative · entry 1

Fleming Harold Edward · CIK 0001857250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083269 · ownership.xml · derivative · entry 1

Mahatme Sandesh · CIK 0001511034 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC
Greene JohnDirector
GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083270 · ownership.xml · derivative · entry 1

Greene John · CIK 0001610732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC
Fardis MariaDirector
GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083268 · ownership.xml · derivative · entry 1

Fardis Maria · CIK 0001559231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $38.57 $0.00
Disclosure

SEC source: 0000950170-25-083267 · ownership.xml · derivative · entry 1

High Katherine A · CIK 0001631248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Shares · 13,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Read SEC document
May 30, 2025 Filed Jun 4, 2025 01:45 UTC
Patel NaimishChief Medical Officer
GrantRestricted Stock Units · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081361 · ownership.xml · derivative · entry 1

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Shares · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

F2 · derivative.expiration_date: This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

Read SEC document
May 30, 2025 Filed Jun 4, 2025 01:45 UTC
Prasad RajuChief Financial Officer
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081362 · ownership.xml · derivative · entry 1

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

F2 · derivative.expiration_date: This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

Read SEC document
May 29, 2025 Filed May 30, 2025 21:00 UTC
Patel NaimishChief Medical Officer
SaleCommon Shares 3,932 $35.94 $141,316.08
Disclosure

SEC source: 0000950170-25-079822 · ownership.xml · nonDerivative · entry 2

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,068

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
May 28, 2025 Filed May 30, 2025 21:00 UTC
Patel NaimishChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-079822 · ownership.xml · derivative · entry 3

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028.

F3 · derivative.expiration_date: This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028.

Read SEC document
May 28, 2025 Filed May 30, 2025 21:00 UTC
Patel NaimishChief Medical Officer
Exercise / conversionCommon Shares 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-079822 · ownership.xml · nonDerivative · entry 1

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
April 03, 2025 Filed Jan 27, 2026 22:35 UTC
Patel NaimishChief Medical Officer
PurchaseCommon Shares 1,508 $32.96 $49,703.68
Disclosure

SEC source: 0001193125-26-024955 · ownership.xml · nonDerivative · entry 1

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,508

F1 · kind: The purchase of Common Shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,508 shares, with a subsequent sale of Common Shares at a price of $35.94 per share on May 29, 2025 pursuant to a mandatory "sell to cover" provision in an award agreement covering a restricted stock unit that vested on such date (and which was reported on a separate Form 4 filing dated May 30, 2025). The Reporting Person has agreed to pay to the Issuer $4,493.84, representing the full amount of the profit realized in connection with the short-swing transaction.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 17:35 UTC
Bruno JulianneChief Operating Officer
SaleCommon Shares 1,714 $41.23 $70,668.22
Disclosure

SEC source: 0000950170-25-043974 · ownership.xml · nonDerivative · entry 2

Bruno Julianne · CIK 0002019645 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,544

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 21:35 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 10,031 $41.23 $413,578.13
Disclosure

SEC source: 0000950170-25-043975 · ownership.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,085

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 21:35 UTC
Prasad RajuChief Financial Officer
SaleCommon Shares 2,197 $41.23 $90,582.31
Disclosure

SEC source: 0000950170-25-043973 · ownership.xml · nonDerivative · entry 2

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,767

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 21:35 UTC
KASINGER JAMES R.General Counsel and Secretary
SaleCommon Shares 3,185 $41.23 $131,317.55
Disclosure

SEC source: 0000950170-25-043972 · ownership.xml · nonDerivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,729

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 17:35 UTC
Bruno JulianneChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043974 · ownership.xml · derivative · entry 4

Bruno Julianne · CIK 0002019645 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Shares · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 17:35 UTC
Bruno JulianneChief Operating Officer
Exercise / conversionCommon Shares 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043974 · ownership.xml · nonDerivative · entry 1

Bruno Julianne · CIK 0002019645 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 19,688 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043975 · ownership.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,062

Underlying: Common Shares · 19,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 19,688 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043975 · ownership.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
Prasad RajuChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043973 · ownership.xml · derivative · entry 3

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Shares · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
Prasad RajuChief Financial Officer
Exercise / conversionCommon Shares 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043973 · ownership.xml · nonDerivative · entry 1

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043972 · ownership.xml · derivative · entry 3

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Shares · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:35 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-043972 · ownership.xml · nonDerivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 21:35 UTC
Prasad RajuChief Financial Officer
SaleCommon Shares 3,762 $41.80 $157,251.60
Disclosure

SEC source: 0000950170-25-041471 · ownership.xml · nonDerivative · entry 2

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,714

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:35 UTC
Patel NaimishChief Medical Officer
GrantRestricted Stock Units · Derivative 32,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-041470 · ownership.xml · derivative · entry 2

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Shares · 32,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:35 UTC
Patel NaimishChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 46,667 $0.00 Strike: $42.12 $0.00
Disclosure

SEC source: 0000950170-25-041470 · ownership.xml · derivative · entry 1

Patel Naimish · CIK 0002021679 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,667

Underlying: Common Shares · 46,667 shares

Expires 2035-03-14

F1 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 46,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 17:35 UTC
Bruno JulianneChief Operating Officer
GrantRestricted Stock Units · Derivative 27,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-041468 · ownership.xml · derivative · entry 2

Bruno Julianne · CIK 0002019645 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,500

Underlying: Common Shares · 27,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 17:35 UTC
Bruno JulianneChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 36,666 $0.00 Strike: $42.12 $0.00
Disclosure

SEC source: 0000950170-25-041468 · ownership.xml · derivative · entry 1

Bruno Julianne · CIK 0002019645 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,666

Underlying: Common Shares · 36,666 shares

Expires 2035-03-14

F1 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:35 UTC
Prasad RajuChief Financial Officer
GrantRestricted Stock Units · Derivative 27,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 5

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,500

Underlying: Common Shares · 27,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F5 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

F5 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:35 UTC
Prasad RajuChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 36,666 $0.00 Strike: $42.12 $0.00
Disclosure

SEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 4

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,666

Underlying: Common Shares · 36,666 shares

Expires 2035-03-14

F4 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:35 UTC
Prasad RajuChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 3

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.